The US Food and Drug Administration (FDA) has approved a higher-dose, lower-frequency regimen for glatiramer acetate (Copaxone, Teva Pharmaceutical Industries) in the treatment of relapsing-remitting ...

The FDA approved Scinopharm's glatiramer acetate injection, a generic version of Copaxone, to treat multiple sclerosis.

The FINANCIAL — Teva Pharmaceutical Industries Ltd. on October 8 announced that the Russian Ministry of Health has approved the Marketing Authorization license (MA) for three-times-a-week COPAXONE ...

Copaxone (glatiramer acetate injection) has potential interactions with other medications. These interactions could cause harmful effects. Copaxone is used in adults to treat relapsing forms of ...

Austria should rethink its opposition to a trade deal between the EU and South America's Mercosur bloc, the country's central bank chief Martin Kocher was quoted as saying on Monday. Reuters, the news ...

Healthcare & Pharmaceuticalscategory Exclusive: Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms 6:03 AM UTC Retail & Consumercategory E. coli outbreak tied to McDonald's ...